News
Collaboration supports manufacture of the OPTF01 product to Drive Next-Generation Chimeric Antigen Receptor T Cell (CAR-T) Development INDIANAPOLIS and EHIME, Japan, May 5, 2025 /PRNewswire/ -- ...
Whether you're a professional or have never touched a design tool or written a line of code, Figma is hoping its AI features ...
Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to dateInitiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) expect ...
Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to date Initiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
MongoDB’s $220 million Voyage AI deal is the only major acquisition in the company’s history. We expect the acquisition of Voyage AI to more than triple MongoDB’s goodwill balance of $70 million as of ...
Unisys has released three new cloud AI solutions under its Cloud, Applications & Infrastructure (CA&I) business unit. These solutions ? Cloud AI Foundation, Cloud AI Enablement, and Cloud AI Customer ...
Vector BioMed (VBM), a leading lentiviral vector CDMO advancing access to gene therapies, will showcase its innovations at two major industry events this May: the International Society for Cell & Gene ...
The Figma design tool receives a range of new tools to generate websites and apps using AI. It also automates content ...
Discover how SVG and DAX can transform Power BI dashboards into stunning, interactive visuals. Learn customization tips and ...
Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results